New insights into long noncoding RNAs and pseudogenes in prognosis of renal cell carcinoma

Table 2 Alterations of LncRNAs and pseudogenes associated with clinical features

Gene	Cases with alteration	Cases without alteration	P-value of metastasis	P-value of stage	P-value of tumour pathologic PT
SPACA6P	35	499	0.06304	0.000003	0.000002
MYH16	23	511	0.03569	0.000161	0.000006
DLEU2	27	507	0.01669	0.000048	0.000006
PIK3CD-AS1	30	504	0.00076	0.000005	0.000007
LINC00520	16	518	0.18129	0.022667	0.000009
RPSAP52	7	527	0.61462	0.00639	0.000014
PLEKHA8P1	45	489	0.00347	0.000016	0.00005
HERC2P2	24	510	0.05581	0.000686	0.000203
NBEAP1	16	518	0.16166	0.000835	0.000222
LINC00623	38	496	0.01218	0.000005	0.000268
ZNF767P	27	507	0.11029	0.000142	0.000323
SNHG17	34	500	0.01181	0.000281	0.000375
ZNF436-AS1	21	513	0.3424	0.000779	0.00046
OR2A9P	40	494	0.04758	0.002167	0.000541
CLCA3P	21	513	0.55887	0.004363	0.000792
LINC00592	27	507	0.28987	0.026707	0.000974
LINC01559	28	506	0.00021	0.000024	0.002526
INGX	23	511	0.00014	0.000142	0.04373
RAET1K	22	512	0.0086	0.000536	0.00129
FKBP9P1	18	516	0.0016	0.000946	0.003459
CXCR2P1	27	507	0.00095	0.004867	0.033003

ISSN: 1475-2867